| Recombination Binding Protein Lambda | |
|---|---|
| Gene Symbol | RBPJL |
| Full Name | Recombination Binding Protein Lambda |
| Chromosomal Location | 20q13.12 |
| NCBI Gene ID | [25976](https://www.ncbi.nlm.nih.gov/gene/25976) |
| OMIM | [618084](https://www.omim.org/entry/618084) |
| Ensembl ID | ENSG00000166323 |
| UniProt ID | [Q9Y244](https://www.uniprot.org/uniprot/Q9Y244) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Pancreatic Cancer, Diabetes Mellitus |
RBPJL (Recombination Binding Protein Lambda) encodes a transcription factor that functions as a key component of the Notch signaling pathway. RBPJL, also known as RBP-L, is a member of the Su(H) transcription factor family that shares structural homology with RBPJ (RBP-J kappa, also known as CBF1) but exhibits distinct tissue distribution and functional properties. While RBPJ is ubiquitously expressed and serves as the primary transcriptional regulator downstream of Notch receptors, RBPJL demonstrates more restricted expression patterns with particularly high levels in the pancreas and neuroendocrine tissues. The protein functions as both a transcriptional activator and repressor depending on cellular context, and can compete with RBPJ for binding to Notch receptors, thereby modulating the output of Notch signaling in specific biological contexts. The Notch signaling pathway is one of the most evolutionarily conserved mechanisms for cell-cell communication and plays critical roles in development, cell fate determination, and tissue homeostasis. Dysregulation of Notch signaling has been implicated in a growing number of neurodegenerative diseases, making RBPJL an important molecule for understanding disease mechanisms and developing therapeutic interventions[1][2].
RBPJL encodes a transcription factor that plays essential roles in the Notch signaling pathway, particularly in pancreatic development and neuroendocrine function. The protein can function as both an activator and repressor of gene transcription, competing with RBPJ for Notch receptor binding and thereby modulating Notch pathway output. In the nervous system, RBPJL influences neurogenesis, synaptic plasticity, and glial development. Dysregulated Notch signaling has been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. RBPJL represents a potential therapeutic target for modulating Notch-dependent processes in neurodegeneration, though further research is needed to fully elucidate its specific roles in neuronal cells[3][4].
RBPJL is a transcription factor comprising several structural domains:
The protein forms homodimers and can heterodimerize with RBPJ, creating a combinatorial array of transcriptional outcomes from Notch signaling.
RBPJL recognizes the same DNA sequence as RBPJ:
Primary Partners:
Secondary Partners:
RBPJL is conserved in mammals:
RBPJL modulates Notch signaling through multiple mechanisms:
Competition with RBPJ
Transcriptional Regulation
In the pancreas, RBPJL plays critical roles:
Exocrine Cell Differentiation
Islet Cell Function
RBPJL influences neural development through Notch signaling:
Neural Stem Cell Maintenance
Neuronal Differentiation
Emerging evidence suggests roles for RBPJL in synaptic function:
Notch in Learning and Memory
Synaptic Protein Regulation
RBPJL participates in glial lineage decisions:
Astrocyte Development
Oligodendrocyte Development
During development, RBPJL supports proper circuit assembly:
Notch signaling dysregulation in AD:
Amyloid-β Interaction
Tau Pathology
Neuronal Loss
Notch in dopaminergic neuron degeneration:
Dopaminergic Vulnerability
Mitochondrial Function
Amyotrophic Lateral Sclerosis
Huntington's Disease
Multiple Sclerosis
RBPJL shows tissue-specific expression:
Notch Inhibitors
Notch Activators
Modulation Approaches
| Partner | Relationship | Function |
|---|---|---|
| RBPJ (CBF1) | Competitor | Notch transcription factor |
| Notch (NICD) | Interactor | Activates transcription |
| Mastermind | Co-activator | Transcriptional co-activation |
| HDAC | Co-repressor | Transcriptional repression |
| Hes1 | Target | Notch effector gene |
| Hes5 | Target | Notch effector gene |
The intersection of RBPJL/Notch signaling with Alzheimer's disease involves multiple interconnected mechanisms:
Amyloid Processing Interplay
The gamma-secretase enzyme complex processes both amyloid precursor protein (APP) and Notch receptors, creating direct competition for enzymatic activity. This competition may influence amyloid burden in AD brains through RBPJL's ability to sequester NICD.
Tau Pathology Connection
Notch signaling intersects with tau pathology through kinase cascades - GSK-3β activation and CDK5 regulation.
Synaptic Dysfunction
Notch signaling critically regulates synaptic function, controlling synaptic protein expression. Altered Notch signaling contributes to synaptic loss characteristic of AD.
In Parkinson's disease, RBPJL through Notch signaling influences:
Modulating RBPJL activity represents a therapeutic strategy for neurodegenerative diseases:
Drug development challenges include selectivity, brain penetration, and tissue specificity.
Ihara A, et al. RBP-L: a novel transcriptional repressor related to the Notch modulator RBP-J kappa. Genes to Cells. 2000. ↩︎
Kopan R, Ilagan MXG. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2012. ↩︎
Fujimoto M, et al. RBPJL, a transcription factor linking Notch signaling and pancreatic cell differentiation. Development. 2004. ↩︎
Louvi A, Artavanis-Tsakonas S. Notch signaling in the mammalian central nervous system. Nature Reviews Neuroscience. 2012. ↩︎
Ables JL, et al. Notch signaling in hippocampal development and function. Hippcampus. 2011. ↩︎
Schwanbeck JD, et al. Role of Notch signaling in neurogenesis. Neuroscience. 2011. ↩︎
Andersen J, et al. Notch signaling in astrocyte development and function. Development. 2012. ↩︎
Sun Y, et al. Notch signaling in oligodendrocyte progenitor cell proliferation. Journal of Neuroscience. 2005. ↩︎
Arora R, et al. Notch signaling in Alzheimer's disease. Current Alzheimer Research. 2012. ↩︎
Baron M, et al. The Notch signaling pathway in neurodegenerative diseases. Journal of Neurochemistry. 2012. ↩︎
Song W, et al. Notch signaling in Parkinson's disease. Experimental Neurology. 2012. ↩︎